MMP9 and Miyoshi myopathy: Along the same lines, MM-derived EVs have been shown to promote osteoclast migration, differentiation and survival, through expression of markers such as CXCR4, RANKL, CTSK, MMP9 and TRAP and activation of the AKT pathway [32], contributing further to the understanding of the lytic bone disease pathogenesis in MM.